Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rigo

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Nature Communications|July 6, 2016
Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analysesKatannya Kapeli, Gabriel A Pratt, Anthony Q Vu, et al.
Cell Reports|September 7, 2017
Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal CancerXiao Ling Li, Murugan Subramanian, Matthew F Jones, et al.
Science (New York, N.Y.)|March 17, 2023
Mechanism of <i>STMN2</i> cryptic splice-polyadenylation and its correction for TDP-43 proteinopathiesMichael W Baughn, Ze'ev Melamed, Jone López-Erauskin, et al.
Neuron|October 25, 2016
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous SystemFernando J Martinez, Gabriel A Pratt, Eric L Van Nostrand, et al.
The Lancet. Neurology|July 26, 2024
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose studyLeonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, et al.
Nature Neuroscience|November 23, 2023
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervationJone López-Erauskin, Mariana Bravo-Hernandez, Maximiliano Presa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Nucleic Acids Research|April 10, 2025
Conjugation to a transferrin receptor 1-binding Bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac musclesMichael E Østergaard, Michele Carrer, Brooke A Anderson, et al.
Scientific Reports|January 6, 2017
The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability statesGuy Barry, James A Briggs, Do Won Hwang, et al.
Lancet (London, England)|May 25, 2025
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case seriesNeil A Shneider, Matthew B Harms, Vlad A Korobeynikov, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Nature Communications|July 6, 2016
Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analysesKatannya Kapeli, Gabriel A Pratt, Anthony Q Vu, et al.
Cell Reports|September 7, 2017
Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal CancerXiao Ling Li, Murugan Subramanian, Matthew F Jones, et al.
Science (New York, N.Y.)|March 17, 2023
Mechanism of <i>STMN2</i> cryptic splice-polyadenylation and its correction for TDP-43 proteinopathiesMichael W Baughn, Ze'ev Melamed, Jone López-Erauskin, et al.
Neuron|October 25, 2016
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous SystemFernando J Martinez, Gabriel A Pratt, Eric L Van Nostrand, et al.
The Lancet. Neurology|July 26, 2024
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose studyLeonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, et al.
Nature Neuroscience|November 23, 2023
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervationJone López-Erauskin, Mariana Bravo-Hernandez, Maximiliano Presa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Nucleic Acids Research|April 10, 2025
Conjugation to a transferrin receptor 1-binding Bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac musclesMichael E Østergaard, Michele Carrer, Brooke A Anderson, et al.
Scientific Reports|January 6, 2017
The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability statesGuy Barry, James A Briggs, Do Won Hwang, et al.
Lancet (London, England)|May 25, 2025
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case seriesNeil A Shneider, Matthew B Harms, Vlad A Korobeynikov, et al.
Pageof 17